372 related articles for article (PubMed ID: 28043905)
1. Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
Nicoletti P; Aithal GP; Bjornsson ES; Andrade RJ; Sawle A; Arrese M; Barnhart HX; Bondon-Guitton E; Hayashi PH; Bessone F; Carvajal A; Cascorbi I; Cirulli ET; Chalasani N; Conforti A; Coulthard SA; Daly MJ; Day CP; Dillon JF; Fontana RJ; Grove JI; Hallberg P; Hernández N; Ibáñez L; Kullak-Ublick GA; Laitinen T; Larrey D; Lucena MI; Maitland-van der Zee AH; Martin JH; Molokhia M; Pirmohamed M; Powell EE; Qin S; Serrano J; Stephens C; Stolz A; Wadelius M; Watkins PB; Floratos A; Shen Y; Nelson MR; Urban TJ; Daly AK;
Gastroenterology; 2017 Apr; 152(5):1078-1089. PubMed ID: 28043905
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
Lucena MI; Molokhia M; Shen Y; Urban TJ; Aithal GP; Andrade RJ; Day CP; Ruiz-Cabello F; Donaldson PT; Stephens C; Pirmohamed M; Romero-Gomez M; Navarro JM; Fontana RJ; Miller M; Groome M; Bondon-Guitton E; Conforti A; Stricker BH; Carvajal A; Ibanez L; Yue QY; Eichelbaum M; Floratos A; Pe'er I; Daly MJ; Goldstein DB; Dillon JF; Nelson MR; Watkins PB; Daly AK; ; ; ; ;
Gastroenterology; 2011 Jul; 141(1):338-47. PubMed ID: 21570397
[TBL] [Abstract][Full Text] [Related]
3. A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
Cirulli ET; Nicoletti P; Abramson K; Andrade RJ; Bjornsson ES; Chalasani N; Fontana RJ; Hallberg P; Li YJ; Lucena MI; Long N; Molokhia M; Nelson MR; Odin JA; Pirmohamed M; Rafnar T; Serrano J; Stefánsson K; Stolz A; Daly AK; Aithal GP; Watkins PB; ;
Gastroenterology; 2019 May; 156(6):1707-1716.e2. PubMed ID: 30664875
[TBL] [Abstract][Full Text] [Related]
4. Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
Nicoletti P; Dellinger A; Li YJ; Barnhart HX; Chalasani N; Fontana RJ; Odin JA; Serrano J; Stolz A; Etheridge AS; Innocenti F; Govaere O; Grove JI; Stephens C; Aithal GP; Andrade RJ; Bjornsson ES; Daly AK; Lucena MI; Watkins PB; ; ;
Gastroenterology; 2023 Mar; 164(3):454-466. PubMed ID: 36496055
[TBL] [Abstract][Full Text] [Related]
5. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
Urban TJ; Shen Y; Stolz A; Chalasani N; Fontana RJ; Rochon J; Ge D; Shianna KV; Daly AK; Lucena MI; Nelson MR; Molokhia M; Aithal GP; Floratos A; Pe'er I; Serrano J; Bonkovsky H; Davern TJ; Lee WM; Navarro VJ; Talwalkar JA; Goldstein DB; Watkins PB; ; ; ; ;
Pharmacogenet Genomics; 2012 Nov; 22(11):784-95. PubMed ID: 22968431
[TBL] [Abstract][Full Text] [Related]
6. Single-nucleotide polymorphisms of
Yang WN; Pang LL; Zhou JY; Qiu YW; Miao L; Wang SY; Liu XZ; Tan KA; Shi WW; Wang GQ; Hou FQ
World J Gastroenterol; 2020 Mar; 26(12):1329-1339. PubMed ID: 32256020
[TBL] [Abstract][Full Text] [Related]
7. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
[TBL] [Abstract][Full Text] [Related]
8. HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury.
Nicoletti P; Werk AN; Sawle A; Shen Y; Urban TJ; Coulthard SA; Bjornsson ES; Cascorbi I; Floratos A; Stammschulte T; Gundert-Remy U; Nelson MR; Aithal GP; Daly AK;
Pharmacogenet Genomics; 2016 May; 26(5):218-24. PubMed ID: 26959717
[TBL] [Abstract][Full Text] [Related]
9. Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.
Nicoletti P; Aithal GP; Chamberlain TC; Coulthard S; Alshabeeb M; Grove JI; Andrade RJ; Bjornsson E; Dillon JF; Hallberg P; Lucena MI; Maitland-van der Zee AH; Martin JH; Molokhia M; Pirmohamed M; Wadelius M; Shen Y; Nelson MR; Daly AK;
Clin Pharmacol Ther; 2019 Jul; 106(1):245-253. PubMed ID: 30661239
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA-C*03:02 with methimazole-induced liver injury in Graves' disease patients.
Li X; Jin S; Fan Y; Fan X; Tang Z; Cai W; Yang J; Xiang X
Biomed Pharmacother; 2019 Sep; 117():109095. PubMed ID: 31202168
[TBL] [Abstract][Full Text] [Related]
11. Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim-Sulfamethoxazole Induced Liver Injury.
Li YJ; Phillips EJ; Dellinger A; Nicoletti P; Schutte R; Li D; Ostrov DA; Fontana RJ; Watkins PB; Stolz A; Daly AK; Aithal GP; Barnhart H; Chalasani N;
Hepatology; 2021 Jan; 73(1):268-281. PubMed ID: 32270503
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
13. Identification and Characterization of Fenofibrate-Induced Liver Injury.
Ahmad J; Odin JA; Hayashi PH; Chalasani N; Fontana RJ; Barnhart H; Cirulli ET; Kleiner DE; Hoofnagle JH
Dig Dis Sci; 2017 Dec; 62(12):3596-3604. PubMed ID: 29119413
[TBL] [Abstract][Full Text] [Related]
14. HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity.
Stephens C; López-Nevot MÁ; Ruiz-Cabello F; Ulzurrun E; Soriano G; Romero-Gómez M; Moreno-Casares A; Lucena MI; Andrade RJ
PLoS One; 2013; 8(7):e68111. PubMed ID: 23874514
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of NAT2, CYP2E1, GST, and HLA related to drug-induced liver injury in indonesian tuberculosis patients.
Perwitasari DA; Darmawan E; Mulyani UA; Vlies PV; Alffenaar JC; Atthobar J; Wilffert B
Int J Mycobacteriol; 2018; 7(4):380-386. PubMed ID: 30531039
[TBL] [Abstract][Full Text] [Related]
16. Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
Urban TJ; Nicoletti P; Chalasani N; Serrano J; Stolz A; Daly AK; Aithal GP; Dillon J; Navarro V; Odin J; Barnhart H; Ostrov D; Long N; Cirulli ET; Watkins PB; Fontana RJ; ; ;
J Hepatol; 2017 Jul; 67(1):137-144. PubMed ID: 28323125
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Oxidative Stress-Related Candidate Genes as Risk Factors for Drug-Induced Liver Injury due to Co-Amoxiclav.
Alshabeeb MA; Aithal GP; Daly AK
DNA Cell Biol; 2020 Mar; 39(3):349-354. PubMed ID: 31905014
[TBL] [Abstract][Full Text] [Related]
18. Genetic risk factors in the development of idiosyncratic drug-induced liver injury.
Stephens C; Lucena MI; Andrade RJ
Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):153-169. PubMed ID: 33222552
[No Abstract] [Full Text] [Related]
19. Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury.
Donaldson PT; Daly AK; Henderson J; Graham J; Pirmohamed M; Bernal W; Day CP; Aithal GP
J Hepatol; 2010 Dec; 53(6):1049-53. PubMed ID: 20800921
[TBL] [Abstract][Full Text] [Related]
20. Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens.
Nicoletti P; Devarbhavi H; Goel A; Venkatesan R; Eapen CE; Grove JI; Zafer S; Bjornsson E; Lucena MI; Andrade RJ; Pirmohamed M; Wadelius M; Larrey D; Maitland-van der Zee AH; Ibanez L; Watkins PB; Daly AK; Aithal GP
Clin Pharmacol Ther; 2021 Apr; 109(4):1125-1135. PubMed ID: 33135175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
